 John Thompson
Concepts (266)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Deep Brain Stimulation | 28 | 2025 | 153 | 10.490 |
Why?
| | Parkinson Disease | 29 | 2025 | 493 | 9.010 |
Why?
| | Subthalamic Nucleus | 15 | 2025 | 72 | 7.410 |
Why?
| | Drug Resistant Epilepsy | 5 | 2025 | 102 | 1.980 |
Why?
| | Epilepsy | 2 | 2025 | 333 | 1.280 |
Why?
| | Wakefulness | 4 | 2025 | 125 | 1.260 |
Why?
| | Globus Pallidus | 3 | 2021 | 26 | 1.260 |
Why?
| | Putamen | 2 | 2020 | 23 | 1.230 |
Why?
| | Sleep Stages | 4 | 2024 | 47 | 1.130 |
Why?
| | Beta Rhythm | 2 | 2024 | 21 | 1.080 |
Why?
| | Basal Ganglia | 3 | 2023 | 56 | 1.070 |
Why?
| | Brain | 6 | 2025 | 2668 | 1.050 |
Why?
| | Brain Waves | 2 | 2017 | 33 | 0.970 |
Why?
| | Sodium Glutamate | 2 | 2016 | 12 | 0.940 |
Why?
| | Pars Reticulata | 2 | 2022 | 6 | 0.940 |
Why?
| | Pedunculopontine Tegmental Nucleus | 2 | 2016 | 4 | 0.940 |
Why?
| | Solitary Nucleus | 2 | 2016 | 23 | 0.940 |
Why?
| | Electrocorticography | 1 | 2025 | 17 | 0.930 |
Why?
| | Sleep | 4 | 2025 | 755 | 0.910 |
Why?
| | Electrodes, Implanted | 7 | 2025 | 109 | 0.900 |
Why?
| | Anterior Thalamic Nuclei | 1 | 2024 | 5 | 0.900 |
Why?
| | Proto-Oncogene Proteins c-fos | 2 | 2016 | 185 | 0.890 |
Why?
| | Seizures | 2 | 2025 | 426 | 0.880 |
Why?
| | Neurons | 9 | 2024 | 1590 | 0.810 |
Why?
| | Thalamus | 3 | 2021 | 107 | 0.800 |
Why?
| | Diffusion Tensor Imaging | 3 | 2021 | 79 | 0.790 |
Why?
| | Methylphenidate | 1 | 2022 | 38 | 0.760 |
Why?
| | Circadian Rhythm | 1 | 2025 | 468 | 0.700 |
Why?
| | Hallucinogens | 1 | 2023 | 105 | 0.690 |
Why?
| | Caudate Nucleus | 1 | 2020 | 23 | 0.680 |
Why?
| | Decision Making | 3 | 2018 | 900 | 0.670 |
Why?
| | Butylated Hydroxytoluene | 2 | 2011 | 38 | 0.650 |
Why?
| | Health Literacy | 1 | 2022 | 168 | 0.640 |
Why?
| | Microelectrodes | 4 | 2024 | 45 | 0.620 |
Why?
| | Middle Aged | 25 | 2025 | 33479 | 0.600 |
Why?
| | Intraoperative Awareness | 1 | 2018 | 3 | 0.590 |
Why?
| | Intraoperative Neurophysiological Monitoring | 2 | 2021 | 21 | 0.580 |
Why?
| | Taste Perception | 2 | 2016 | 31 | 0.560 |
Why?
| | Polysomnography | 5 | 2024 | 185 | 0.560 |
Why?
| | White Matter | 1 | 2019 | 145 | 0.550 |
Why?
| | Male | 37 | 2025 | 67762 | 0.540 |
Why?
| | Humans | 50 | 2025 | 137585 | 0.540 |
Why?
| | Aged | 19 | 2025 | 23961 | 0.500 |
Why?
| | Glioma | 2 | 2021 | 395 | 0.500 |
Why?
| | Essential Tremor | 3 | 2024 | 15 | 0.490 |
Why?
| | Space Perception | 1 | 2016 | 80 | 0.490 |
Why?
| | Cannabis | 1 | 2023 | 494 | 0.480 |
Why?
| | Dystonia | 3 | 2024 | 25 | 0.470 |
Why?
| | Choice Behavior | 1 | 2016 | 170 | 0.450 |
Why?
| | Lac Operon | 1 | 2014 | 44 | 0.450 |
Why?
| | Mental Recall | 1 | 2016 | 202 | 0.450 |
Why?
| | beta-Galactosidase | 1 | 2014 | 78 | 0.450 |
Why?
| | Female | 28 | 2025 | 73304 | 0.440 |
Why?
| | Movement Disorders | 1 | 2014 | 58 | 0.430 |
Why?
| | tau Proteins | 1 | 2014 | 90 | 0.420 |
Why?
| | Laser Therapy | 3 | 2021 | 130 | 0.400 |
Why?
| | Neuroma, Acoustic | 2 | 2024 | 51 | 0.400 |
Why?
| | Dystonic Disorders | 2 | 2024 | 25 | 0.400 |
Why?
| | Models, Neurological | 1 | 2014 | 242 | 0.390 |
Why?
| | Tremor | 3 | 2023 | 65 | 0.380 |
Why?
| | Magnetic Resonance Imaging | 5 | 2024 | 3566 | 0.370 |
Why?
| | Hypokinesia | 2 | 2022 | 8 | 0.360 |
Why?
| | Cannabinoid Receptor Modulators | 1 | 2010 | 8 | 0.350 |
Why?
| | Xenobiotics | 1 | 2011 | 32 | 0.350 |
Why?
| | Finches | 1 | 2010 | 14 | 0.350 |
Why?
| | Vocalization, Animal | 1 | 2010 | 33 | 0.340 |
Why?
| | Oxidants | 1 | 2011 | 111 | 0.340 |
Why?
| | Pilot Projects | 3 | 2025 | 1710 | 0.330 |
Why?
| | Endocannabinoids | 1 | 2010 | 63 | 0.330 |
Why?
| | Glutamic Acid | 1 | 2010 | 246 | 0.300 |
Why?
| | Neuronal Plasticity | 1 | 2010 | 290 | 0.280 |
Why?
| | Action Potentials | 3 | 2024 | 493 | 0.280 |
Why?
| | Alcohol Oxidoreductases | 1 | 2008 | 62 | 0.280 |
Why?
| | Carcinogens | 1 | 2008 | 125 | 0.280 |
Why?
| | Learning | 1 | 2010 | 409 | 0.260 |
Why?
| | Trapezoid Body | 2 | 2016 | 9 | 0.240 |
Why?
| | Electroencephalography | 2 | 2025 | 423 | 0.240 |
Why?
| | Adult | 12 | 2025 | 37929 | 0.240 |
Why?
| | Implantable Neurostimulators | 1 | 2025 | 17 | 0.230 |
Why?
| | Motor Activity | 3 | 2021 | 718 | 0.230 |
Why?
| | Superior Colliculi | 2 | 2015 | 40 | 0.230 |
Why?
| | Animals | 14 | 2022 | 36940 | 0.230 |
Why?
| | Enzyme Inhibitors | 1 | 2008 | 840 | 0.230 |
Why?
| | Cavernous Sinus | 1 | 2024 | 19 | 0.230 |
Why?
| | Actigraphy | 1 | 2025 | 110 | 0.230 |
Why?
| | Young Adult | 5 | 2025 | 13209 | 0.220 |
Why?
| | Antioxidants | 1 | 2008 | 584 | 0.220 |
Why?
| | Pneumocephalus | 1 | 2024 | 4 | 0.220 |
Why?
| | Mice, Transgenic | 4 | 2016 | 2167 | 0.200 |
Why?
| | Treatment Outcome | 9 | 2024 | 10811 | 0.200 |
Why?
| | Ear, Inner | 1 | 2023 | 49 | 0.200 |
Why?
| | Cannabinoid Receptor Agonists | 1 | 2023 | 46 | 0.200 |
Why?
| | Taste | 2 | 2016 | 229 | 0.200 |
Why?
| | Mice, Inbred C57BL | 5 | 2021 | 5757 | 0.200 |
Why?
| | Reward | 2 | 2016 | 244 | 0.200 |
Why?
| | Proof of Concept Study | 1 | 2022 | 78 | 0.190 |
Why?
| | Observer Variation | 1 | 2023 | 343 | 0.190 |
Why?
| | Intralaminar Thalamic Nuclei | 1 | 2022 | 16 | 0.190 |
Why?
| | Tertiary Care Centers | 1 | 2023 | 160 | 0.190 |
Why?
| | Cannabidiol | 1 | 2024 | 119 | 0.190 |
Why?
| | Substantia Nigra | 1 | 2022 | 57 | 0.180 |
Why?
| | Psychosurgery | 1 | 2021 | 8 | 0.180 |
Why?
| | Surgical Wound Infection | 1 | 2025 | 307 | 0.180 |
Why?
| | Skull Base | 2 | 2020 | 53 | 0.180 |
Why?
| | Upper Extremity | 1 | 2022 | 99 | 0.180 |
Why?
| | Zona Incerta | 1 | 2021 | 3 | 0.180 |
Why?
| | Retrospective Studies | 8 | 2025 | 15657 | 0.180 |
Why?
| | Mice | 8 | 2021 | 17787 | 0.180 |
Why?
| | Dronabinol | 1 | 2024 | 226 | 0.180 |
Why?
| | Craniotomy | 1 | 2021 | 77 | 0.180 |
Why?
| | Anesthesia, General | 1 | 2021 | 77 | 0.170 |
Why?
| | Neurosurgical Procedures | 2 | 2024 | 197 | 0.170 |
Why?
| | Anticonvulsants | 1 | 2023 | 217 | 0.170 |
Why?
| | Conscious Sedation | 1 | 2021 | 92 | 0.170 |
Why?
| | Consensus | 1 | 2023 | 683 | 0.160 |
Why?
| | Atrophy | 1 | 2020 | 184 | 0.160 |
Why?
| | Robotic Surgical Procedures | 1 | 2021 | 130 | 0.160 |
Why?
| | Biomechanical Phenomena | 1 | 2022 | 810 | 0.150 |
Why?
| | Extracellular Vesicles | 1 | 2021 | 146 | 0.150 |
Why?
| | Evoked Potentials, Auditory | 1 | 2020 | 180 | 0.150 |
Why?
| | Neoplasm Grading | 1 | 2019 | 307 | 0.150 |
Why?
| | Psychoacoustics | 1 | 2018 | 10 | 0.150 |
Why?
| | Brain Mapping | 1 | 2021 | 503 | 0.150 |
Why?
| | Intraoperative Period | 1 | 2018 | 59 | 0.140 |
Why?
| | Corpus Striatum | 1 | 2020 | 167 | 0.140 |
Why?
| | Behavior, Animal | 1 | 2021 | 501 | 0.140 |
Why?
| | Reproducibility of Results | 2 | 2023 | 3284 | 0.140 |
Why?
| | Lung | 1 | 2011 | 4060 | 0.140 |
Why?
| | Psychotic Disorders | 1 | 2020 | 170 | 0.140 |
Why?
| | Neuropsychological Tests | 1 | 2022 | 1023 | 0.140 |
Why?
| | Algorithms | 1 | 2025 | 1704 | 0.130 |
Why?
| | Orientation | 2 | 2015 | 48 | 0.130 |
Why?
| | REM Sleep Behavior Disorder | 1 | 2016 | 14 | 0.130 |
Why?
| | Epilepsy, Temporal Lobe | 1 | 2017 | 38 | 0.130 |
Why?
| | Mice, Inbred BALB C | 2 | 2011 | 1272 | 0.130 |
Why?
| | Acoustic Stimulation | 1 | 2018 | 312 | 0.130 |
Why?
| | Biomarkers | 2 | 2025 | 4149 | 0.130 |
Why?
| | Stereotaxic Techniques | 1 | 2016 | 39 | 0.130 |
Why?
| | Grape Seed Extract | 2 | 2013 | 44 | 0.130 |
Why?
| | Referral and Consultation | 1 | 2022 | 786 | 0.130 |
Why?
| | Brain Injuries | 1 | 2021 | 494 | 0.120 |
Why?
| | Cadaver | 3 | 2024 | 296 | 0.120 |
Why?
| | Postoperative Complications | 2 | 2025 | 2654 | 0.120 |
Why?
| | Drinking | 1 | 2016 | 42 | 0.120 |
Why?
| | Odorants | 1 | 2016 | 109 | 0.120 |
Why?
| | Vision Disorders | 1 | 2017 | 142 | 0.120 |
Why?
| | Imaging, Three-Dimensional | 1 | 2019 | 580 | 0.120 |
Why?
| | Amygdala | 1 | 2017 | 191 | 0.120 |
Why?
| | Cues | 1 | 2018 | 314 | 0.120 |
Why?
| | Neoplasm Staging | 1 | 2019 | 1389 | 0.120 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2019 | 752 | 0.120 |
Why?
| | Stimulation, Chemical | 1 | 2014 | 59 | 0.110 |
Why?
| | Dyskinesias | 1 | 2014 | 19 | 0.110 |
Why?
| | Acetylcholine | 1 | 2015 | 185 | 0.110 |
Why?
| | Anxiety | 1 | 2022 | 1035 | 0.110 |
Why?
| | Staining and Labeling | 1 | 2014 | 150 | 0.110 |
Why?
| | Synapses | 2 | 2016 | 427 | 0.110 |
Why?
| | Psychometrics | 1 | 2018 | 720 | 0.110 |
Why?
| | Optogenetics | 1 | 2015 | 108 | 0.110 |
Why?
| | Membrane Potentials | 1 | 2014 | 284 | 0.110 |
Why?
| | Anthocyanins | 1 | 2013 | 33 | 0.100 |
Why?
| | Schizophrenia | 1 | 2017 | 439 | 0.100 |
Why?
| | Symptom Assessment | 1 | 2014 | 128 | 0.100 |
Why?
| | Neural Inhibition | 1 | 2014 | 169 | 0.100 |
Why?
| | Cytokines | 1 | 2021 | 2085 | 0.100 |
Why?
| | Smell | 1 | 2013 | 117 | 0.100 |
Why?
| | Locomotion | 1 | 2013 | 106 | 0.100 |
Why?
| | Equipment Design | 1 | 2014 | 522 | 0.100 |
Why?
| | Stroke | 1 | 2021 | 1120 | 0.100 |
Why?
| | Receptors, Androgen | 1 | 2013 | 150 | 0.100 |
Why?
| | Task Performance and Analysis | 1 | 2013 | 183 | 0.100 |
Why?
| | STAT3 Transcription Factor | 1 | 2013 | 206 | 0.090 |
Why?
| | Biflavonoids | 1 | 2011 | 9 | 0.090 |
Why?
| | Proanthocyanidins | 1 | 2011 | 10 | 0.090 |
Why?
| | Glucuronides | 1 | 2011 | 18 | 0.090 |
Why?
| | Microsomes, Liver | 1 | 2011 | 86 | 0.090 |
Why?
| | Hippocampus | 1 | 2017 | 895 | 0.090 |
Why?
| | Catechin | 1 | 2011 | 24 | 0.090 |
Why?
| | Nerve Net | 1 | 2014 | 256 | 0.090 |
Why?
| | Reactive Nitrogen Species | 1 | 2011 | 21 | 0.090 |
Why?
| | Glutathione Transferase | 1 | 2011 | 106 | 0.090 |
Why?
| | Adolescent | 3 | 2025 | 21513 | 0.090 |
Why?
| | Antineoplastic Agents, Phytogenic | 1 | 2011 | 191 | 0.080 |
Why?
| | Dendritic Spines | 1 | 2010 | 65 | 0.080 |
Why?
| | Endoscopy | 2 | 2024 | 318 | 0.080 |
Why?
| | NF-kappa B | 1 | 2013 | 691 | 0.080 |
Why?
| | Time Factors | 1 | 2020 | 6828 | 0.080 |
Why?
| | Glutathione | 1 | 2011 | 356 | 0.080 |
Why?
| | Alkylation | 1 | 2008 | 26 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2010 | 289 | 0.070 |
Why?
| | Reactive Oxygen Species | 1 | 2011 | 622 | 0.070 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2008 | 180 | 0.070 |
Why?
| | Cytosol | 1 | 2008 | 226 | 0.070 |
Why?
| | Lung Neoplasms | 2 | 2011 | 2526 | 0.060 |
Why?
| | Neural Pathways | 2 | 2020 | 295 | 0.060 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2008 | 597 | 0.060 |
Why?
| | Diphosphonates | 1 | 2006 | 66 | 0.060 |
Why?
| | Recombinant Proteins | 1 | 2008 | 1353 | 0.060 |
Why?
| | Sella Turcica | 1 | 2024 | 18 | 0.060 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4295 | 0.060 |
Why?
| | Neuroendoscopy | 1 | 2024 | 23 | 0.060 |
Why?
| | Patch-Clamp Techniques | 2 | 2016 | 286 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.060 |
Why?
| | Facial Nerve | 1 | 2024 | 38 | 0.050 |
Why?
| | Biomarkers, Tumor | 1 | 2011 | 1276 | 0.050 |
Why?
| | Diffusion Magnetic Resonance Imaging | 1 | 2024 | 153 | 0.050 |
Why?
| | Edema | 1 | 2023 | 130 | 0.050 |
Why?
| | Adrenergic Agents | 1 | 2021 | 6 | 0.050 |
Why?
| | Oxidopamine | 1 | 2021 | 17 | 0.050 |
Why?
| | Parkinson Disease, Secondary | 1 | 2021 | 7 | 0.050 |
Why?
| | Mitochondria | 1 | 2008 | 948 | 0.050 |
Why?
| | Evoked Potentials, Motor | 1 | 2021 | 46 | 0.050 |
Why?
| | Immunohistochemistry | 2 | 2016 | 1738 | 0.040 |
Why?
| | Corpus Callosum | 1 | 2021 | 71 | 0.040 |
Why?
| | Sleep Wake Disorders | 1 | 2024 | 286 | 0.040 |
Why?
| | Electric Impedance | 1 | 2020 | 107 | 0.040 |
Why?
| | Nose | 1 | 2020 | 67 | 0.040 |
Why?
| | Fingers | 1 | 2020 | 88 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2024 | 1993 | 0.040 |
Why?
| | Melanoma | 1 | 2006 | 760 | 0.040 |
Why?
| | Movement | 1 | 2020 | 278 | 0.030 |
Why?
| | Dreams | 1 | 2016 | 11 | 0.030 |
Why?
| | Meningioma | 1 | 2018 | 91 | 0.030 |
Why?
| | Visual Pathways | 1 | 2017 | 55 | 0.030 |
Why?
| | Visual Fields | 1 | 2017 | 90 | 0.030 |
Why?
| | Meningeal Neoplasms | 1 | 2018 | 100 | 0.030 |
Why?
| | Synaptosomal-Associated Protein 25 | 1 | 2016 | 25 | 0.030 |
Why?
| | Gerbillinae | 1 | 2016 | 65 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 101 | 0.030 |
Why?
| | Spatial Behavior | 1 | 2015 | 26 | 0.030 |
Why?
| | Spinal Cord | 1 | 2018 | 370 | 0.030 |
Why?
| | Exploratory Behavior | 1 | 2015 | 92 | 0.030 |
Why?
| | Fluorescence | 1 | 2015 | 160 | 0.030 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 402 | 0.030 |
Why?
| | Glycine Plasma Membrane Transport Proteins | 1 | 2014 | 5 | 0.030 |
Why?
| | Cholera Toxin | 1 | 2014 | 32 | 0.030 |
Why?
| | Rhodamines | 1 | 2014 | 20 | 0.030 |
Why?
| | Heterocyclic Compounds, 3-Ring | 1 | 2014 | 32 | 0.030 |
Why?
| | Electroporation | 1 | 2014 | 38 | 0.030 |
Why?
| | Antineoplastic Agents | 1 | 2006 | 2129 | 0.030 |
Why?
| | Photic Stimulation | 1 | 2015 | 241 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 294 | 0.030 |
Why?
| | Glutamate Decarboxylase | 1 | 2014 | 170 | 0.030 |
Why?
| | Electric Stimulation | 1 | 2014 | 264 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2021 | 3556 | 0.030 |
Why?
| | Functional Laterality | 1 | 2014 | 223 | 0.030 |
Why?
| | Single-Cell Analysis | 1 | 2016 | 313 | 0.030 |
Why?
| | Green Fluorescent Proteins | 1 | 2014 | 390 | 0.020 |
Why?
| | Prognosis | 1 | 2021 | 4030 | 0.020 |
Why?
| | In Vitro Techniques | 1 | 2014 | 1092 | 0.020 |
Why?
| | Brain Neoplasms | 1 | 2021 | 1238 | 0.020 |
Why?
| | Animals, Newborn | 1 | 2014 | 844 | 0.020 |
Why?
| | Dimerization | 1 | 2011 | 199 | 0.020 |
Why?
| | Methylation | 1 | 2011 | 230 | 0.020 |
Why?
| | Palliative Care | 1 | 2017 | 758 | 0.020 |
Why?
| | Risk Factors | 1 | 2025 | 10388 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1120 | 0.020 |
Why?
| | Quality of Life | 1 | 2022 | 2892 | 0.020 |
Why?
| | Prospective Studies | 1 | 2021 | 7604 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2016 | 2828 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2017 | 5131 | 0.020 |
Why?
| | Age Factors | 1 | 2014 | 3295 | 0.020 |
Why?
| | Cell Proliferation | 1 | 2013 | 2475 | 0.020 |
Why?
| | Prostatic Neoplasms | 1 | 2013 | 1043 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2013 | 3412 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2006 | 7635 | 0.010 |
Why?
|
|
Thompson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|